These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9243327)

  • 1. Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs.
    Inami M; Kawamura I; Naoe Y; Tsujimoto S; Mizota T; Manda T; Shimomura K
    Jpn J Pharmacol; 1997 Jun; 74(2):187-94. PubMed ID: 9243327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.
    Hirosumi J; Nakayama O; Chida N; Inami M; Fagan T; Sawada K; Shigematsu S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):365-73. PubMed ID: 7734405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (1) In vitro effects on human and animal prostatic enzymes.
    Hirosumi J; Nakayama O; Fagan T; Sawada K; Chida N; Inami M; Takahashi S; Kojo H; Notsu Y; Okuhara M
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):357-63. PubMed ID: 7734404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic study of a new nonsteroidal 5 alpha-reductase inhibitor, 4-[3-[3-[Bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-yl]-butyr ic acid, in rats.
    Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):914-20. PubMed ID: 9495849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-(1-benzoylindol-3-yl)butyric acids and FK143: novel nonsteroidal inhibitors of steroid 5 alpha-reductase (II).
    Sawada K; Okada S; Golden P; Kayakiri N; Sawada Y; Hashimoto M; Tanaka H
    Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):481-91. PubMed ID: 10319427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats.
    Yasuda N; Fujino K; Shiraji T; Nambu F; Kondo K
    Jpn J Pharmacol; 1997 Jul; 74(3):243-52. PubMed ID: 9268084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genes.
    Kojo H; Nakayama O; Hirosumi J; Chida N; Notsu Y; Okuhara M
    Mol Pharmacol; 1995 Sep; 48(3):401-6. PubMed ID: 7565619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
    Katashima M; Yamamoto K; Haraguchi K; Tokuma Y; Hata T; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Sep; 25(9):1051-8. PubMed ID: 9311620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
    Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.
    Homma Y; Kaneko M; Kondo Y; Kawabe K; Kakizoe T
    J Natl Cancer Inst; 1997 Jun; 89(11):803-7. PubMed ID: 9182979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Tagawa M; Ikeda R
    J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
    Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH
    Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of chlormadinone acetate (CMA), antiandrogen, on the pituitary, testis, prostate and adrenal gland of the dog with spontaneous benign prostatic hyperplasia.
    Murakoshi M; Ikeda R; Fukui N
    J Toxicol Sci; 2001 Aug; 26(3):119-27. PubMed ID: 11552295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T; Honma S; Mieda M
    Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats.
    Maruyama S; Nagasue N; Dhar DK; Yamanoi A; El-Assal ON; Satoh K; Okita K
    Clin Cancer Res; 2001 Jul; 7(7):2096-104. PubMed ID: 11448929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M; Ikada R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M; Ikeda R; Tagawa M; Nakayama T
    Tokai J Exp Clin Med; 1999 Jun; 24(2):77-83. PubMed ID: 10641996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic oral administration of a selective 5 alpha-reductase inhibitor, finasteride, on the dog prostate.
    Laroque PA; Prahalada S; Gordon LR; Noblot SM; Bagdon WJ; Duprat P; Peter CP; Van Zwieten MJ
    Prostate; 1994; 24(2):93-100. PubMed ID: 8309848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
    Takezawa Y; Ito K; Suzuki K; Fukabori Y; Yamanaka H; Honma S; Mieda M; Hamataki N; Kushitani M
    Prostate; 1995 Dec; 27(6):321-8. PubMed ID: 7501544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.